This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Facts about Diphosphomevalonate decarboxylase.
Human | |
---|---|
Gene Name: | MVD |
Uniprot: | P53602 |
Entrez: | 4597 |
Belongs to: |
---|
diphosphomevalonate decarboxylase family |
EC 4.1.1.33; FP17780; MDDase; mevalonate (diphospho) decarboxylase; Mevalonate (diphospho)decarboxylase; Mevalonate pyrophosphate decarboxylase; MPDdiphosphomevalonate decarboxylase
Mass (kDA):
43.405 kDA
Human | |
---|---|
Location: | 16q24.2 |
Sequence: | 16; NC_000016.10 (88651935..88663153, complement) |
Expressed in heart, skeletal muscle, lung, liver, brain, pancreas, kidney and placenta.
You've come to right place if you want to learn more about Steven Boster and his work. This Boster bio will provide you with an overview of the man, His work, and His family. There are also interesting facts about Marker. Read on to find out more. Here are the Best Uses For the MVD Marker.
Steve Boster was born in 1965 and died on June 6, 2022. He was the son of James and Evelyn Meier and had worked in retail sales for many years. Steve was also an active member of Concordia Hall, Staunton, VA.
Steve Boster's initial product was an ELISA. The company began with hundreds upon hundreds of primary antibody samples and quickly became the largest in China. PicoKine(tm), a patent-pending ELISA platform, allows scientists to test samples with unprecedented accuracy. Steven Boster's life is full of milestones that have made him a legend within the biotechnology industry.
His work with MVD markers provided new insights about the effectiveness of antiangiogenic drugs. However, the use of this marker does not necessarily equate to a better prognosis for patients. To determine which vessel marker proves to be more reliable, further research will be needed. His findings provide a new outlook on clinical practice. This article will be more in-depth. Continue reading to learn about MVD, and the possible applications of this marker.
The effects of intratumoral neonevascularization have complex consequences. They can impact tumor growth, metastasis, treatment, and even death. MVD measurement using imaging technology is expected to be a reliable index of tumor angiogenesis and can be used to improve the effectiveness of treatment. It represents a huge unexplored area in the study of tumor heterogeneity. Imaging indicators of tumor angiogenicity could be more reproducible.
PMID: 8626466 by Toth M.J., et al. Molecular cloning and expression of the cDNAs encoding human and yeast mevalonate pyrophosphate decarboxylase.
PMID: 9392419 by Hinson D.D., et al. Post-translational regulation of mevalonate kinase by intermediates of the cholesterol and nonsterol isoprene biosynthetic pathways.
*More publications can be found for each product on its corresponding product page